VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Huo TI, Lin HC, Huang YH et al. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer 107(1), 141–148 (2006).
  MedlineGoogle Scholar
• 2 Miyoshi A, Kitajima Y, Kido S et al. Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br. J. Cancer 92(2), 252–258 (2005).• Highlights that the upregulated MMPs expression induced by Snail can significantly promote the invasion of hepatocellular carcinoma.
  Medline CASGoogle Scholar
• 3 Sugimachi K, Tanaka S, Kameyama T et al. Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin. Cancer Res. 9(7), 2657–2664 (2003).•• Highlights that epithelial–mesenchymal transition is a critical mechanism in metastasis of hepatocellular carcinoma.
  Medline CASGoogle Scholar
• 4 Yang AD, Camp ER, Fan F et al. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res. 66(1), 46–51 (2006).
  Medline CASGoogle Scholar
• 5 Schwartz JD, Rowinsky EK, Youssoufian H, Pytowski B, Wu Y. Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1). Cancer 116(4 Suppl.), 1027–1032 (2010).•• An excellent review about the function and clinical value of VEGFR-1 in human cancer.
  Medline CASGoogle Scholar
• 6 Ng IO, Poon RT, Lee JM, Fan ST, Ng M, Tso WK. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am. J. Clin. Pathol. 116(6), 838–845 (2001).
  Medline CASGoogle Scholar
• 7 Wu Y, Hooper AT, Zhong Z et al. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma. Int. J. Cancer 119(7), 1519–1529 (2006).
  Medline CASGoogle Scholar
• 8 Price DJ, Miralem T, Jiang S, Steinberg R, Avraham H. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ. 12(3), 129–135 (2001).
  Medline CASGoogle Scholar
• 9 Bates RC, Goldsmith JD, Bachelder RE et al. Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids. Curr. Biol. 13(19), 1721–1727 (2003).
  Medline CASGoogle Scholar
• 10 Yi ZY, Feng LJ, Xiang Z et al. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in hepatocellular carcinoma cells. J. Invest. Surg. 24(2), 67–76 (2011).•• First paper to indicate that VEGFR-1 activation can induce epithelial–mesenchymal transition in hepatocellular carcinoma and promote its metastasis.
  MedlineGoogle Scholar
• 11 Mira E, Mañes S, Lacalle RA, Márquez G, Martínez-A C. Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9. Endocrinology 140(4), 1657–1664 (1999).
  Medline CASGoogle Scholar
• 12 Sun L, Diamond ME, Ottaviano AJ, Joseph MJ, Ananthanarayan V, Munshi HG. Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol. Cancer Res. 6(1), 10–20 (2008).
  Medline CASGoogle Scholar
• 13 Zuo JH, Zhu W, Li MY et al. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J. Cell Biochem. 112(9), 2508–2517 (2011).
  Medline CASGoogle Scholar
• 14 Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25(1), 9–34 (2006).
  Medline CASGoogle Scholar
• 15 Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2(3), 161–174 (2002).
  Medline CASGoogle Scholar
• 16 Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol. 10(6), 415–433 (2000).
  Medline CASGoogle Scholar
• 17 Bergers G, Brekken R, McMahon G et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2(10), 737–744 (2000).
  Medline CASGoogle Scholar
• 18 Hiratsuka S, Nakamura K, Iwai S et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2(4), 289–300 (2002).•• Highlights that MMP-9 expression induced by VEGFR-1 is involved in cancer metastasis.
  Medline CASGoogle Scholar
• 19 Zhang S, Li J, Jiang Y, Xu Y, Qin C. Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells. J. Exp. Clin. Cancer Res. 28, 71(2009).
  Medline CASGoogle Scholar
• 20 Chen R, Cui J, Xu C et al. The significance of MMP-9 Over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection. Ann. Surg. Oncol. 19(Suppl. 3), S375–S384 (2012).•• Highlights that MMP-9 rather than MMP-2 expression is closely involved with hepatocellular carcinoma invasion.
  MedlineGoogle Scholar
• 21 Yung S, Davies M. Response of the human peritoneal mesothelial cell to injury: an in vitro model of peritoneal wound healing. Kidney Int. 54(6), 2160–2169 (1998).
  Medline CASGoogle Scholar
• 22 Ottaviano AJ, Sun L, Ananthanarayanan V, Munshi HG. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. Cancer Res. 66(14), 7032–7040 (2006).
  Medline CASGoogle Scholar
• 23 Jordà M, Olmeda D, Vinyals A et al. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J. Cell Sci. 118(Pt15), 3371–3385 (2005).
  Medline CASGoogle Scholar
• 24 Xu Y, Zhu M, Zhang S, Liu H, Li T, Qin C. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma. Pathol. Oncol. Res. 16(2), 169–175 (2010).
  Medline CASGoogle Scholar
• 25 Toi M, Bando H, Ogawa T, Muta M, Hornig C, Weich HA. Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer. Int. J. Cancer 98(1), 14–18 (2002).
  Medline CASGoogle Scholar
• 26 Tang J, Cui J, Chen R et al. A three-dimensional cell biology model of human hepatocellular carcinoma in vitro. Tumour Biol. 32(3), 469–479 (2011).
  MedlineGoogle Scholar
• 27 Fukase K, Ohtsuka H, Onogawa T et al. Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma. Cancer Sci. 99(9), 1785–1792 (2008).
  Medline CASGoogle Scholar
• 28 Hipp S, Walch A, Schuster T et al. Activation of epidermal growth factor receptor results in snail protein but not mRNA overexpression in endometrial cancer. J. Cell Mol. Med. 13(9B), 3858–3867 (2009).
  MedlineGoogle Scholar
• 29 Wanami LS, Chen HY, Peiró S, García de Herreros A, Bachelder RE. Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression. Exp. Cell Res. 314(13), 2448–2453 (2008).
  Medline CASGoogle Scholar
• 30 Amaoka N, Saio M, Nonaka K et al. Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma. Oncol. Rep. 16(1), 3–10 (2006).•• Highlights that VEGFR-1 was expressed in the hepatocellular carcinoma tissue and was confirmed as a functional receptor associated with histological grade.
  Medline CASGoogle Scholar
• 31 Jia JB, Zhuang PY, Sun HC et al. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival. J. Cancer Res. Clin. Oncol. 135(6), 847–854 (2009).
  Medline CASGoogle Scholar
• 32 Wey JS, Fan F, Gray MJ et al. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer 104(2), 427–438 (2005).
  Medline CASGoogle Scholar
• 33 Kanda M, Nomoto S, Nishikawa Y et al. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. J. Surg. Oncol. 98(3), 190–196 (2008).
  Medline CASGoogle Scholar
• 34 Laird A, O'Mahony FC, Nanda J et al. Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome. PLoS ONE 8(4), e60483 (2013).•• Highlights that VEGFR-1 could serve as a prognostic marker for other type of malignancy.
  Medline CASGoogle Scholar
• 35 Fan F, Wey JS, McCarty MF et al. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene 24(16), 2647–2653 (2005).
  Medline CASGoogle Scholar
• 36 Libra M, Scalisi A, Vella N et al. Uterine cervical carcinoma: role of matrix metalloproteinases (review). Int. J. Oncol. 34(4), 897–903 (2009).
  Medline CASGoogle Scholar
• 37 Köhrmann A, Kammerer U, Kapp M et al. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature. BMC Cancer 9, 188 (2009).
  MedlineGoogle Scholar
• 38 Lin CY, Tsai PH, Kandaswami CC et al. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci. 102(4), 815–827 (2011).
  Medline CASGoogle Scholar